Disc Medicine Inc (IRON)

Currency in USD
76.57
-0.02(-0.03%)
Closed·
76.570.00(0.00%)
·
IRON is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
75.2577.90
52 wk Range
40.0099.50
Key Statistics
Prev. Close
76.57
Open
76.69
Day's Range
75.25-77.9
52 wk Range
40-99.5
Volume
520.62K
Average Volume (3m)
926.15K
1-Year Change
-14.6757%
Book Value / Share
15.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRON Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
126.77
Upside
+65.56%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period

Disc Medicine Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 126.77
(+65.56% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy132.00+72.39%-New Coverage09-11-2026
H.C. Wainwright
Buy127.00+65.86%120.00Maintain06-11-2026
Jefferies
Buy149.00+94.59%128.00Maintain21-10-2026
Morgan Stanley
Buy92.00+20.15%90.00Maintain20-10-2026
Cantor Fitzgerald
Buy170.00+122.02%125.00Maintain20-10-2026

Disc Medicine Inc SWOT Analysis


Pipeline Promise
Disc Medicine's bitopertin and DISC-0974 show potential in rare blood disorders, with NDA filing for bitopertin expected in late 2025
Market Opportunity
Expanded patient estimates for EPP/XLP and substantial anemia treatment market present significant revenue potential for Disc Medicine
Catalysts Ahead
Key milestones include NDA filing, Phase 2 data readouts, and new trial initiations, potentially driving stock performance and valuation
Analyst Optimism
Price targets range from $75 to $132, reflecting confidence in Disc Medicine's pipeline and market potential despite current unprofitability
Read full SWOT analysis

Earnings

Latest Release
05-11-2026
EPS / Forecast
-1.53 / -1.63
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

IRON Income Statement

Compare IRON to Peers and Sector

Metrics to compare
IRON
Peers
Sector
Relationship
P/E Ratio
−14.3x−7.4x−0.2x
PEG Ratio
0.86−0.160.00
Price/Book
5.8x2.0x2.6x
Price / LTM Sales
-26.5x2.7x
Upside (Analyst Target)
65.6%142.5%68.5%
Fair Value Upside
Unlock6.8%11.5%Unlock

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
18.04M39.62%1.38B
Other Institutional Investors
34.37M60.38%2.63B
Public Companies & Retail Investors
0.000.00%0.00
Total
52.41M100.00%4.01B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC10.55%48,02,9943,67,861
Access Industries, Inc.6.02%27,39,3292,09,805

FAQ

What Is the Disc Medicine (IRON) Share Price Today?

The Disc Medicine share price today is 76.57.

What is the current Disc Medicine (IRON) share price and day range?

As of 18-11-2026, the Disc Medicine share price is 76.57, with a previous close of 76.57. The share price has ranged from 75.25 to 77.90 today, while the 52-week range spans from 40.00 to 99.50.

What Is the Disc Medicine Market Cap?

As of today, Disc Medicine market cap is 3.49B.

What Is the Disc Medicine (IRON) Share Price Target?

The average 12-month share price target for Disc Medicine is 126.77, with a high estimate of 170 and a low estimate of 92. 13 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +65.56% Upside potential.

What Is Disc Medicine's Earnings Per Share (TTM)?

The Disc Medicine EPS (TTM) is -6.33.

When Is the Next Disc Medicine Earnings Date?

Disc Medicine will release its next earnings report on 04-03-2027.

From a Technical Analysis Perspective, Is IRON a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does Disc Medicine Trade On?

Disc Medicine is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Disc Medicine?

The stock symbol for Disc Medicine is "IRON."

How Many Times Has Disc Medicine Stock Split?

Disc Medicine has split 1 times.

How Many Employees Does Disc Medicine Have?

Disc Medicine has 173 employees.

What Is the IRON Premarket Price?

IRON's last pre-market stock price is 77.45. The pre-market share volume is 3,690.00, and the stock has changed by 0.86, or 1.12%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.